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National and global support for  
services that enable women and their 
partners to have access to a full range 
of quality contraceptives are growing 
rapidly, as evidenced through the  
financial commitments made during 
the London Summit on Family Planning, 
and the ensuing FP2020 Initiative that 
seeks to reduce unmet need for such 
services by 120 million women. 
With these investments, and the anticipated increases  
in effective contraceptive use, come expectations of sub-
stantial and demonstrable impacts on a range of health 
outcomes, including significant reductions in unintended 
pregnancies, maternal, newborn and child deaths and 
unsafe abortions.
Attributing health outcomes to a specific health interven-
tion is always challenging, and direct measurement of 
outcomes averted is not possible. Consequently, several 
statistical models have been developed that estimate the 
number of health outcomes that will be averted because 
of contraceptive use. The table on page 3 describes and 
compares five of the most commonly used approaches: 
Adding it Up (AIU); Impact2; ImpactNow; Reality Check; 
and FamPlan/LiST. AIU is used by staff at the Guttmach-
er Institute for undertaking and presenting analyses of 
outcomes and is not in the public domain; the other four 
estimation models have been developed for use at national 
and sub-national levels by donors, programme managers 
and policymakers. While these are the most frequently 
used approaches to measure the impact of contracep-
tive use, other models are available that address similar 
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APPROACHES FOR MEASURING  
THE IMPACT OF CONTRACEPTIVE USE
Adding it up (AIU)
ORGANISATION:  Guttmacher Institute
CONTACT: Jacqueline E. Darroch  
(JEDarroch@guttmacher.org)
WEBSITE: Darroch, J, Singh S. 2011. Adding It Up:  
The Costs And Benefits Of Investing In  
Family Planning And Maternal And Newborn 
Health—Estimation Methodology. New York: 
Guttmacher Institute.  
www.guttmacher.org/pubs/AIU-methodology.pdf 
Impact2
ORGANISATION:  Marie Stopes International
CONTACT: Michelle Weinberger  
(michelle.weinberger@mariestopes.org)
WEBSITE: Marie Stopes International. 2012. Impact 2: 
An innovative tool for measuring the impact of 
reproductive health programmes. London:  
Marie Stopes International.  
www.mariestopes.org/impact-2 
ImpactNow
ORGANISATION:  USAID Health Policy Project, Futures 
Group
CONTACT: Ellen Smith  
(esmith@futuresgroup.com)
WEBSITE: Not yet available
Reality Check
ORGANISATION:  USAID RESPOND Project, EngenderHealth 
CONTACT: Melanie Yahner  
(myahner@engenderhealth.org) 
WEBSITE: Not yet available  www.respond-project.org
FamPlan/LiST
ORGANISATION:  USAID Health Policy Project, Futures 
Institute 
CONTACT: John Stover  
(jstover@futuresinstitute.org) 
WEBSITE: Spectrum Manual: Spectrum System of Policy 
Models: www.futuresinstitute.org/spectrum.aspx
questions. The Crosswalk document1 helps advocates, 
programme planners, decision makers, and others select 
which among these tools might best address their goals or 
questions, as well as provide insight into how to interpret the 
outputs of each tool.
However, concerns have been expressed that this range of 
approaches—which overlap in the impacts they estimate, but 
sometimes use different inputs, mathematical algorithms and 
assumptions, and may produce different results—may be 
confusing for policy makers, managers and donors who want 
to measure or evaluate these impacts. To address these 
concerns, the STEP UP consortium convened two expert 
meetings (in September 2013 and March 2014) to review the 
estimation methods used; come to consensus on methodolo-
gies and assumptions, where possible; and provide guidance 
to those wanting to measure such impacts. Following the 
first meeting, the same data from four countries (Bangladesh, 
Burkina Faso, Colombia, Malawi) were inputted into each 
model and the estimates generated for numerous impacts 
were compared. Substantial differences emerged, which 
provided the basis for intensive discussions between the 
model developers during the second meeting. These discus-
sions led to modifications in the models through reaching a 
consensus on the following core elements.
PREGNANCY RATES
Pregnancy rates are important for determining the likelihood 
of a pregnancy among sexually active, fecund women who 
do not want to become pregnant when contraception is not 
used. Agreement was reached that the same pregnancy rate 
for a “non-user at risk of unintended pregnancy” should be 
used as the default where applicable in all models and kept 
constant for the foreseeable future. Using the AIU methodol-
ogy, the estimated pregnancy rate among women with unmet 
need using no method across 148 developing countries is 
31%, with an inter-quartile plausibility range of 23-38%. This 
rate is calculated by dividing the number of unintended preg-
nancies among the estimated number of women with unmet 
need using no method, by the total number of women with 
unmet need using no method. This rate is lower than some 
previous estimates. It should be noted that this default preg-
nancy rate will be adopted by the models Impact2, Impact-
Now, Reality Check and FamPlan but the published tables in 
Adding It Up will continue to use Guttmacher’s estimates of 
regional pregnancy rates.
CONTRACEPTIVE METHOD FAILURE RATES
Agreement was reached that the same method failure rates 
should be used where applicable in all models because it is 
important to ensure that the estimated impact of using con-
traception takes into account the fact that no method is 100% 
effective. The group recommended using the method-specif-
ic rates calculated by Cleland, Ali & Shah1 and by Trussell.2 
Moreover, agreement was reached that these rates should 
not be adjusted for individual countries because: i) it is not 
possible to distinguish unintended pregnancy by method 
used in national settings; and ii) these global estimates are 
widely accepted. As with the pregnancy rates, this consen-
sus will be implemented by the models Impact 2, ImpactNow, 
Reality Check and FamPlan; the Adding It Up analysis will 
continue to be based on the adjusted failure rates estimated 
by Guttmacher staff, which differ by region.
ESTIMATING ABORTIONS AND  
MISCARRIAGES AVERTED
AIU, Reality Check, and FamPlan will use the “% of unintend-
ed pregnancies ending in abortion” rates estimated by the 
Guttmacher Institute. Impact2 and ImpactNow currently apply 
sub-regional abortion ratios to the number of live births avert-
ed, and will explore using the Guttmacher Institute’s unintend-
ed pregnancy ratios instead. The models estimate the number 
of miscarriages averted slightly differently, but the differences 
are very minor and so no change was deemed necessary.
MATERNAL DEATHS AVERTED
Published national maternal mortality ratios (MMR) represent 
the overall risk of maternal mortality given the national distri-
bution of pregnancy outcomes (births, abortions, miscarriag-
es). Applying these ratios to estimates of live births averted 
by contraceptive use does not accurately represent the risk 
of maternal mortality of an adjusted distribution on unintend-
ed pregnancies (see above). Reality Check and FamPlan will 
adapt the AIU approach to adjusting the national maternal 
mortality ratio estimations,4 to reflect the adjusted distribution 
of unintended pregnancy outcomes.  This adjustment will 
be done using WHO sub-regional unsafe abortion rates and 
a Guttmacher Institute estimate of two deaths per 100,000 
safe abortions. Impact2 and ImpactNow will explore using 
this adjusted approach as part of exploring adjusting preg-
nancy outcomes based on pregnancy intention.
1 Godbole R, Smith E. 2012. Crosswalk of Family Planning Tools: A Guide to Costing, Planning, and Impact Analysis Tools. Washington, DC: Health Policy 
Project, USAID, Bureau for Global Health. 
2 Cleland J, Ali MM, and Shah I. 2006. “Dynamics of contraceptive use”, in: UN Department of Economic and Social Affairs, Population Division, Levels and 
Trends of Contraceptive Use as Assessed in 2002, pp. 87–115, Table 22, page 98.
3 Trussell J. 2007. “Contraceptive efficacy,” in: Hatcher RA et al. (eds.), Contraceptive Technology, 19th ed., New York: Ardent Media. 
4  http://maternalmortalitydata.org/mme.html
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Adding It Up
Guttmacher Institute
Impact 2
MSI
ImpactNow
Futures Group
Reality Check
EngenderHealth
FamPlan/LiST
Futures Institute
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Illustrate the health and 
financial costs and benefits 
of modern contraceptive use 
in terms of outcomes averted 
through current or full (i.e.  
no unmet need) contracep-
tive use.
Estimate the current and potential 
future impacts of FP service 
provision on adverse outcomes 
averted through comparing current 
contraceptive use (modelled from 
service statistics) with no use;
Estimate the quantity of contracep-
tive services needed to reach a 
specified contraceptive prevalence 
goal.
Estimate the health and eco-
nomic impacts of contraceptive 
use in the near-term; automatic 
scenario comparisons facilitate 
creation of advocacy messages. 
Can also estimate impacts for a 
given FP budget.
Estimate the resources 
required to maintain or reach 
a specified contraceptive 
prevalence, increase by a 
certain annual rate, or meet 
unmet need;
Estimate the potential impact 
of achieving this goal on 
averting adverse outcomes.
Estimate the resources required to 
meet contraceptive goals, such as 
reducing unmet need, achieving 
a specified modern contraceptive 
prevalence gaol, or achieving a 
goal of reduced total fertility.
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No input required from user.
Tabulations of most recent 
national surveys (e.g. DHS, 
MICS); estimations for 
missing data:
−	 Method use;
−	 Unmet need (by marital 
status and spacing/
limiting);
−	 Sub-regional estimates 
of unintended pregnancies
−	 Estimated proportions of 
pregnancy outcomes for 
birth, safe/unsafe abortion 
and miscarriage;
−	 Maternal death rate and 
DALYs (for all women and 
those with abortions).
Required input from user:
Quantity of services provided 
annually; or programme goal (CPR, 
additional users).
The following inputs have defaults 
which can be overridden by the 
user:
−	 Demographic data from UN 
Population Projections;
−	 DHS and UN Population Divi-
sion data on CPR, unmet need, 
% married;
−	 Special studies for method 
effectiveness and CYP factors;
−	 Costs & coverage by of mater-
nal & neonatal interventions 
from UN Reproductive Health 
Costing Tool
The following inputs have default 
values, which can be overridden 
by the user:
−	 Demographic data from UN 
Population Projections;
−	 DHS and UN Population 
Division data on CPR, unmet 
need, % Married;
−	 Special studies for method 
effectiveness and discontin-
uation;
−	 Costs & coverage by of mater-
nal & neonatal interventions 
from UN Reproductive Health 
Costing Tool and others;
−	 Unit costs of FP provision (by 
method).
The following inputs have 
default values which can be 
overridden by the user:
−	 Method discontinuation, 
CYP factors, per-unit costs, 
pregnancy rate, unintended 
pregnancy outcomes, 
maternal mortality ratio;
−	 Tabulations of most recent 
national surveys (e.g. DHS, 
MICS) for CPR;
−	 Demographic data from  
UN Population Projections.
The following inputs have default 
values preloaded, which cannot be 
overridden by the user:
−	 Demographic data on popu-
lation by age and sex in base 
year, TFR, age distribution of 
fertility, sex ratio at birth, life 
expectancy at birth, migration 
by age and sex from UN Popu-
lation Projections.
−	 DHS data on method mix, source 
mix, proximate determinants of 
fertility, costs of FP by method 
and source, method effective-
ness, CYP factors, and percent 
of births that are high risk;
−	 Data from special studies for 
method effectiveness and CYP 
factors.
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Impacts estimated:
−	 Unintended pregnancies;
−	 Unintended births (live 
& still);
−	 Safe & unsafe abortions;
−	 Miscarriages;
−	 Maternal deaths;
−	 DALYs;
−	 Contraceptive service 
costs;
−	 Maternal and newborn 
health care costs.
Programme outcomes:
−	 FP users by method
−	 Contribution to CPR
−	 Services needed to reach goal
Impacts averted:
−	 Unintended pregnancies;
−	 Live births;
−	 Safe & unsafe abortions;
−	 Maternal & child deaths;
−	 DALYs;
−	 Direct costs saved to families 
and healthcare systems (mater-
nal & neonatal).
Programme outcomes:
−	 FP users and acceptors, by 
method
−	 CPR;
−	 Unmet need;
−	 FP budget required (depend-
ing on configuration chosen)
Impacts averted:
−	 Unintended pregnancies;
−	 Live births;
−	 Safe & unsafe abortions;
−	 Maternal & child deaths;
−	 DALYs;
−	 Maternal & neonatal costs 
averted;
−	 Cost-benefit ratio;
−	 ICER (Incremental Cost- 
Effectiveness Ratio).
Programme outcomes:
−	 FP users and acceptors;
−	 Commodities
Commodity costs
Impacts averted:
−	 Unintended pregnancies;
−	 Live births;
−	 Safe & unsafe abortions;
−	 Maternal deaths.
Programme outcomes:
−	 TFR;
−	 CPR;
−	 FP users and acceptors, by 
method and source;
−	 Unmet need;
−	 Average method effectiveness;
−	 CYP;
−	 Commodities required;
−	 Contraceptive service costs;
−	 Percentage of births with  
demographic risk factors;
−	 Pregnancies;
−	 Births by mother’s age, birth 
interval and parity;
−	 Abortions;
−	 Maternal deaths, by type;
−	 Infant and under 5 mortality rates
Impacts averted:
−	 Impacts can be calculated 
for any of the programme 
outcomes listed above  
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Apply current proportion of 
sub-regional unintended 
pregnancies that end in 
abortions (safe & unsafe) 
to unintended pregnancies 
averted.   
Apply sub-regional abortion ratios 
to the number of live births averted 
nationally; Live births averted  
calculated by subtracting estimated 
abortions, stillbirths, and miscar-
riages from pregnancies averted.
Apply sub-regional abortion 
ratios to the number of live 
births averted nationally; Live 
births averted calculated by 
subtracting estimated abortions, 
stillbirths, and miscarriages from 
pregnancies averted.
Apply current proportion of 
sub-regional unintended 
pregnancies that end in 
abortions (safe & unsafe) 
to unintended pregnancies 
averted.   
Number of abortions calculated 
from an assumed total abortion 
rate, or as a percentage of  
unintended pregnancies. 
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births, safe & unsafe abor-
tions averted; Ratios based 
on WHO country MMR, 
WHO regional unsafe abor-
tion mortality and estimated 
safe abortion mortality.
Apply the national maternal mortal-
ity ratio to the number of live births 
averted Default MMR values from 
WHO provided.
Apply the national maternal 
mortality ratio to the number of 
live births averted. Default MMR 
values from WHO provided.
Apply MMR to number of live 
births averted. Default MMR 
values from WHO provided.
Apply MMR to the number of live 
births. 
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Attribute infant mortality 
reduction to fewer births.  
Apply WHO or IHME mortal-
ity rates to unplanned births 
averted.
Country-specific coefficient applied 
to the number of live births; this 
coefficient estimates the effect of 
longer birth intervals on decreasing 
child mortality.
Apply coefficient developed using 
PSI methodology for birth spacing 
impact. 
Country-specific coefficient 
applied to the number of live 
births; this coefficient estimates 
the effect of longer birth intervals 
on decreasing child mortality.
Apply coefficient developed 
using PSI methodology for birth 
spacing impact.
Infant and child deaths 
averted are not outputs of 
the tool.
Deaths averted result from two fac-
tors: 1) contraception leads to fewer 
births which result in fewer deaths, 
2) contraception leads to fewer 
risky births (high parity, closely 
spaced, mother’s age <18 or >35) 
which can reduce mortality rates 
and thus result in fewer deaths. 
INFANT AND CHILD DEATHS AVERTED
The estimates of infant and child deaths averted are recog-
nized as the weakest elements of these models because 
the relationship between contraceptive use and infant and 
child mortality is still being clarified. However, these impacts 
are requested by many users for advocacy purposes and 
so all models are looking to improve the estimation meth-
ods; for example, Impact2 and FamPlan are exploring how 
contraceptive use changes the distribution of birth spacing 
risks and subsequent child mortality. AIU currently estimates 
infant deaths averted due to a reduction in the number of 
births (i.e. the demographic effect), rather than changes in 
risk and will explore integrating findings regarding changes 
in birth spacing.
IMPLICATIONS FOR MEASURING THE 
IMPACT OF CONTRACEPTIVE USE
These meetings and modelling exercises provided an import-
ant and unique opportunity for those involved in the develop-
ment of estimation methodologies to come together and to 
discuss the various approaches used. This review process 
enabled the group to identify where and why differences 
existed and to seek alignment for harmonising the model-
ling approaches more closely. As a result, the estimation 
methodologies for each approach have been coordinated 
and consensus reached to ensure that, wherever possi-
ble, they are not in conflict. This alignment and consensus 
building process has strengthened the models by enabling 
their developers to benefit from each other’s’ experience 
and research. Moreover, decision-makers and managers 
using the different models can more clearly understand the 
assumptions behind each model so as to make informed 
choices between them.
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